Hematopoietic stem cell: self‐renewal versus differentiation

The mammalian blood system, containing more than 10 distinct mature cell types, stands on one specific cell type, hematopoietic stem cell (HSC). Within the system, only HSCs possess the ability of both multipotency and self‐renewal. Multipotency is the ability to differentiate into all functional blood cells. Self‐renewal is the ability to give rise to HSC itself without differentiation. Since mature blood cells (MBCs) are predominantly short‐lived, HSCs continuously provide more differentiated progenitors while properly maintaining the HSC pool size throughout life by precisely balancing self‐renewal and differentiation. Thus, understanding the mechanisms of self‐renewal and differentiation of HSC has been a central issue. In this review, we focus on the hierarchical structure of the hematopoietic system, the current understanding of microenvironment and molecular cues regulating self‐renewal and differentiation of adult HSCs, and the currently emerging systems approaches to understand HSC biology. Copyright © 2010 John Wiley & Sons, Inc.

[1]  L. Hood,et al.  Dysregulated gene expression networks in human acute myelogenous leukemia stem cells , 2009, Proceedings of the National Academy of Sciences.

[2]  I. Weissman,et al.  The Adhesion Molecule Esam1 Is a Novel Hematopoietic Stem Cell Marker , 2009, Stem cells.

[3]  A. Iwama,et al.  TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. , 2009, Blood.

[4]  I. Weissman,et al.  Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis. , 2009, Blood.

[5]  Satoru Miyano,et al.  Transcriptional profiling of hematopoietic stem cells by high-throughput sequencing , 2009, International journal of hematology.

[6]  Subhajyoti De,et al.  BloodExpress: a database of gene expression in mouse haematopoiesis , 2008, Nucleic Acids Res..

[7]  I. Weissman,et al.  Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. , 2008, Blood.

[8]  W. Birchmeier,et al.  Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. , 2008, Blood.

[9]  H. Macdonald,et al.  Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis. , 2008, Blood.

[10]  H. Macdonald,et al.  Simultaneous loss of β- and γ-catenin does not perturb hematopoiesis or lymphopoiesis , 2008 .

[11]  T. Reya,et al.  Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo , 2007 .

[12]  I. Weissman,et al.  Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. , 2007, Cell stem cell.

[13]  Steven B. Bradfute,et al.  Hematopoietic fingerprints: an expression database of stem cells and their progeny. , 2007, Cell stem cell.

[14]  K. Akashi,et al.  Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. , 2007, Cell stem cell.

[15]  David Bryder,et al.  Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. , 2007, Cell stem cell.

[16]  I. Weissman,et al.  Hematopoietic Stem Cell Quiescence Attenuates DNA Damage Response and Permits DNA Damage Accumulation During Aging , 2007, Cell cycle.

[17]  H. Nakauchi,et al.  Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction , 2007, Proceedings of the National Academy of Sciences.

[18]  T. Reya,et al.  Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. , 2007, Cancer cell.

[19]  J. Dick,et al.  Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment , 2006, Nature Immunology.

[20]  B. Porse,et al.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.

[21]  C. Shaw,et al.  Evidence for Diversity in Transcriptional Profiles of Single Hematopoietic Stem Cells , 2006, PLoS genetics.

[22]  K. Anderson,et al.  Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. , 2006, Genes & development.

[23]  I. Weissman,et al.  New Evidence Supporting Megakaryocyte-Erythrocyte Potential of Flk2/Flt3+ Multipotent Hematopoietic Progenitors , 2006, Cell.

[24]  F. Rosenbauer,et al.  Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. , 2006, Nature immunology.

[25]  I. Weissman,et al.  Stem cell research: paths to cancer therapies and regenerative medicine. , 2005, JAMA.

[26]  I. Weissman,et al.  Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells , 2005, PLoS genetics.

[27]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[28]  I. Weissman,et al.  Cell intrinsic alterations underlie hematopoietic stem cell aging. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Lodish,et al.  Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. , 2005, Blood.

[30]  H. Nakauchi,et al.  Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. , 2005, Developmental cell.

[31]  Lina A. Thoren,et al.  Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential A Revised Road Map for Adult Blood Lineage Commitment , 2005, Cell.

[32]  S. E. Jacobsen,et al.  Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. , 2005, Blood.

[33]  J. Massagué,et al.  Transforming growth factor (cid:1) -induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation , 2022 .

[34]  Keisuke Ito,et al.  Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.

[35]  H. Macdonald,et al.  β-Catenin Is Dispensable for Hematopoiesis and Lymphopoiesis , 2004, The Journal of experimental medicine.

[36]  J. Dick,et al.  Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. , 2004, Blood.

[37]  M. Goumans,et al.  TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. , 2003, Blood.

[38]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[39]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[40]  A. Bernstein,et al.  Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  I. Weissman,et al.  Gene expression analysis of purified hematopoietic stem cells and committed progenitors. , 2003, Blood.

[42]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[43]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[44]  Xi C. He,et al.  Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. , 2003, Blood.

[45]  John T. Dimos,et al.  A Stem Cell Molecular Signature , 2002, Science.

[46]  Irving L. Weissman,et al.  Prospective isolation of human clonogenic common myeloid progenitors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Pawson,et al.  Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice , 2002, The Journal of experimental medicine.

[48]  I. Weissman,et al.  Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. , 2002, The Journal of clinical investigation.

[49]  Roger E Bumgarner,et al.  Differential gene expression profiling of adult murine hematopoietic stem cells. , 2002, Blood.

[50]  J. Nolta,et al.  Molecular mechanism of transforming growth factor b – mediated cell-cycle modulation in primary human CD 34 1 progenitors , 2001 .

[51]  Tao Cheng,et al.  Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). , 2001, Blood.

[52]  J. Armitage,et al.  Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[53]  I. Weissman,et al.  Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[55]  S. Jacobsen,et al.  Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. , 2001, Immunity.

[56]  I. Weissman,et al.  Dendritic Cell Development from Common Myeloid Progenitors , 2001, Annals of the New York Academy of Sciences.

[57]  I. Weissman,et al.  Dendritic cell potentials of early lymphoid and myeloid progenitors. , 2001, Blood.

[58]  M. Goumans,et al.  Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice , 2001, The EMBO journal.

[59]  D. Scadden,et al.  Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). , 2001, Blood.

[60]  J. Dick,et al.  Distinct classes of human stem cells that differ in proliferative and self-renewal potential , 2001, Nature Immunology.

[61]  I. Weissman,et al.  Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor , 2000 .

[62]  R. Perlmutter,et al.  Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. , 2000, Immunity.

[63]  N. Fortunel,et al.  p21cip1 mRNA is controlled by endogenous transforming growth factor‐β1 in quiescent human hematopoietic stem/progenitor cells , 2000 .

[64]  G. Salles,et al.  Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. , 2000, Experimental hematology.

[65]  I. Weissman,et al.  Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[66]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[67]  N. Fortunel,et al.  TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. , 2000, Journal of cell science.

[68]  I. Weissman,et al.  Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. , 2000, Science.

[69]  N. Fortunel,et al.  p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells. , 2000, Journal of cellular physiology.

[70]  K. Moore,et al.  Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. , 1999, Blood.

[71]  N. Taylor,et al.  Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[72]  I. Weissman,et al.  HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  F.J. Sauvage,et al.  Role of c-mpl in early hematopoiesis. , 1998, Blood.

[74]  N. Fortunel,et al.  High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells. , 1998, Journal of cell science.

[75]  I. Weissman,et al.  High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. , 1998, The Journal of clinical investigation.

[76]  A. Roberts,et al.  Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[77]  M. Mihm,et al.  Involvement of interleukin-3 in delayed-type hypersensitivity. , 1998, Blood.

[78]  K. Yasukawa,et al.  Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. , 1997, Blood.

[79]  C. Schmoor,et al.  Transforming growth factor‐beta 1 delays formation of granulocyte‐macrophage colony‐forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells , 1997, British journal of haematology.

[80]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[81]  C. Begley,et al.  Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. , 1997, Blood.

[82]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[83]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[85]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[86]  G. Crooks,et al.  Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. , 1996, Blood.

[87]  M. Taketo,et al.  TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.

[88]  R. Nishinakamura,et al.  Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. , 1996, Blood.

[89]  I. Weissman,et al.  The aging of hematopoietic stem cells , 1996, Nature Medicine.

[90]  Hiromitsu Nakauchi,et al.  Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.

[91]  F. Ruscetti,et al.  Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. , 1996, Blood.

[92]  T. Soma,et al.  Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-beta but not macrophage inflammatory protein-1 alpha activities. , 1996, Blood.

[93]  C. Eaves,et al.  Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[94]  F. D. de Sauvage,et al.  Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin , 1996, The Journal of experimental medicine.

[95]  K. Shiota,et al.  Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[96]  M. Fackler,et al.  CD34: structure, biology, and clinical utility. , 1996, Blood.

[97]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[98]  A. Galy,et al.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.

[99]  B. Lim,et al.  Early CD34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit. , 1995, Blood.

[100]  Thomas N. Sato,et al.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.

[101]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[102]  M. Ichihara,et al.  Impaired interleukin‐3 (IL‐3) response of the A/J mouse is caused by a branch point deletion in the IL‐3 receptor alpha subunit gene. , 1995, The EMBO journal.

[103]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[104]  A. Gurney,et al.  Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.

[105]  M. Gertsenstein,et al.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.

[106]  A. Tsukamoto,et al.  Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. , 1994, Blood.

[107]  F. Ruscetti,et al.  Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. , 1994, Blood.

[108]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[109]  L. Terstappen,et al.  Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. , 1994, Blood.

[110]  L. Terstappen,et al.  Lymphoid and Myeloid Differentiation of Single Human CD 34 + , HLA-DR + , CD 38-Hematopoietic Stem Cells , 2002 .

[111]  Thomas N. Sato,et al.  Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[112]  A. Iwama,et al.  Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. , 1993, Biochemical and biophysical research communications.

[113]  M. Ogawa,et al.  Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.

[114]  D. Printz,et al.  Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. , 1993, Blood.

[115]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[116]  J. Rossant,et al.  tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. , 1992, Oncogene.

[117]  I. Weissman,et al.  Isolation of a candidate human hematopoietic stem-cell population. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[118]  I. Weissman,et al.  Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[119]  I. Weissman,et al.  Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow , 1992, The Journal of experimental medicine.

[120]  A. Roberts,et al.  Bidirectional effects of transforming growth factor beta (TGF-beta) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-beta isoforms. , 1991, Blood.

[121]  J. Hatzfeld,et al.  Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides , 1991, The Journal of experimental medicine.

[122]  S. Jacobsen,et al.  Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. , 1991, Blood.

[123]  I. Weissman,et al.  Clonal analysis of hematopoietic stem-cell differentiation in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[124]  David A. Williams,et al.  Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.

[125]  C. Dubois,et al.  Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action , 1990, The Journal of experimental medicine.

[126]  A. Reith,et al.  W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. , 1990, Genes & development.

[127]  A. Bernstein,et al.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. , 1989, Genes & development.

[128]  D. Jarboe,et al.  The mast cell-committed progenitor. II. W/Wv mice do not make mast cell-committed progenitors and S1/S1d fibroblasts do not support development of normal mast cell-committed progenitors. , 1989, Journal of immunology.

[129]  Y. Kanakura,et al.  In vitro duplication and in vivo cure of mast-cell deficiency of Sl/Sld mutant mice by cloned 3T3 fibroblasts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[130]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[131]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[132]  I. Weissman,et al.  Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule , 1987, Cell.

[133]  I. Weissman,et al.  Isolation of two early B lymphocyte progenitors from mouse marrow: A committed Pre-Pre-B cell and a clonogenic Thy-1lo hematopoietic stem cell , 1986, Cell.

[134]  M. Fackler,et al.  Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. , 1984, Journal of immunology.

[135]  E. Russell,et al.  Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. II. Effects on mast cell development. , 1983, Experimental hematology.

[136]  Y. Kitamura,et al.  Decreased production of mast cells in S1/S1d anemic mice. , 1979, Blood.

[137]  Y. Kitamura,et al.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. , 1978, Blood.

[138]  S. Boggs,et al.  Reduced Blood and Marrow Neutrophils and Granulocytic Colony-Forming Cells in Sl/Sld Mice 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[139]  S. Ebbe,et al.  Abnormalities of Megakaryocytes in Sl/Sld Mice , 1973 .

[140]  S. Ebbe,et al.  Abnormalities of megakaryocytes in W-WV mice. , 1973, Blood.

[141]  S. Ebbe,et al.  Abnormalities of megakaryocytes in S1-S1d mice. , 1973, Blood.

[142]  M. C. Green,et al.  An experimental analysis of the pigment defect caused by mutations at the W and S1 loci in mice. , 1968, Developmental biology.

[143]  E. Russell,et al.  Proof of whole-cell implant in therapy of W-series anemia. , 1968, Archives of biochemistry and biophysics.

[144]  E. Russell,et al.  TWO HEREDITARY MOUSE ANEMIAS (Sl/Sld and W/Wv) DEFICIENT IN RESPONSE TO ERYTHROPOIETIN * , 1968 .

[145]  J. Till,et al.  CYTOLOGICAL EVIDENCE FOR A RELATIONSHIP BETWEEN NORMAL HEMATOPOIETIC COLONY-FORMING CELLS AND CELLS OF THE LYMPHOID SYSTEM , 1968, The Journal of experimental medicine.

[146]  J. Till,et al.  THE DISTRIBUTION OF COLONY-FORMING CELLS AMONG SPLEEN COLONIES. , 1963, Journal of cellular and comparative physiology.

[147]  J. Till,et al.  Cytological Demonstration of the Clonal Nature of Spleen Colonies Derived from Transplanted Mouse Marrow Cells , 1963, Nature.

[148]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.

[149]  P. Sarvella,et al.  STEEL, A NEW DOMINANT GENE IN THE HOUSE MOUSEWith Effects on Coat Pigment and Blood , 1956 .

[150]  E. Russell.  Analysis of pleiotropism at the W-locus in the mouse; relationship between the effects of W and Wv substitution on hair pigmentation and on erythrocytes. , 1949, Genetics.